{"id":"etoricoxib-cyanocobalamin-fixed-dose","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset (nausea, dyspepsia)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Hypertension"}]},"_chembl":{"chemblId":"CHEMBL2110563","moleculeType":"Small molecule","molecularWeight":"1356.40"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces prostaglandin synthesis, thereby decreasing inflammation and pain. Cyanocobalamin is an essential B vitamin required for neurological function, DNA synthesis, and erythrocyte maturation. This fixed-dose combination likely targets pain conditions where B12 deficiency or neurological involvement may be present.","oneSentence":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while cyanocobalamin (vitamin B12) supports neurological function and red blood cell formation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:11:46.260Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory pain conditions (likely osteoarthritis, rheumatoid arthritis, or musculoskeletal pain with concurrent B12 deficiency)"}]},"trialDetails":[{"nctId":"NCT06517823","phase":"PHASE3","title":"Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-26","conditions":"Acute Low-back Pain","enrollment":190}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Etori + Cyano"],"phase":"phase_3","status":"active","brandName":"Etoricoxib + Cyanocobalamin fixed dose","genericName":"Etoricoxib + Cyanocobalamin fixed dose","companyName":"Laboratorios Silanes S.A. de C.V.","companyId":"laboratorios-silanes-s-a-de-c-v","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while cyanocobalamin (vitamin B12) supports neurological function and red blood cell formation. Used for Inflammatory pain conditions (likely osteoarthritis, rheumatoid arthritis, or musculoskeletal pain with concurrent B12 deficiency).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}